Pharma
We drive evolution where it really matters
At Izertis we support pharmaceutical and Life Sciences companies in transforming their commercial, operational and technological models, connecting strategy, data and regulation to generate real and sustainable impact.
+60
Pharmaceutical companies trust us
+150
Specialised projects in the sector
Leader
In CRM services in Europe
360º
CRM, AI, Compliance and Commercial Efficiency
With a deep specialisation in the Pharma ecosystem
We combine technology innovation and industry solutions to improve business efficiency, accelerate AI adoption, and ensure regulatory compliance in highly regulated environments. We do not offer adapted generic technology: we build solutions from real knowledge.
Leaders in NEXTGEN technological change
The pharmaceutical industry is experiencing a structural change in its CRM ecosystem. The migration to new models forces each company to make strategic decisions that will mark its competitiveness over the next decade.
Support in decision-making processes
We don't just implement technology. We accompany companies in every phase of the decision process.
-
Definition of the future operating model, ligning technology with the omnichannel commercial strategy.
-
Detailed transition roadmap with milestones, dependencies, risk management and rollback plan.
-
Organisational impact assessment: people, processes, data governance and change management.
Salesforce Life Sciences Cloud implementation
Our approach combines functional depth with technical pragmatism, ensuring that each module deployed responds to a validated business process in the field.
-
Functional design aligned with real business processes: visit cycles, medical segmentation, sample management, and promotional activities.
-
Native integration with key ecosystems: IQVIA, corporate ERP, BI platforms.
-
Accelerated implementation methodology.
Maintenance and optimisation of systems
Evolution and continuous improvement of CRM systems in production, acting as a natural extension of our customers' IT teams.
-
Managed service with defined SLAs, N2/N3 support and planned evolutives.
-
Continuous improvement programmes based on usage, adoption and performance metrics.
-
Active reduction of technical debt: refactoring, legacy configuration clean-up and integration optimisation.
-
Governance and change control with release management processes, sandbox management and live documentation.
Our differential
We understand CRM as a strategic lever for business transformation, not as a technical tool. Every design, configuration and integration decision is aimed at improving the effectiveness of the sales network and the relationship with the healthcare professional.
Improvement of Sales Force Effectiveness
The pressure on commercial ROI in Pharma is increasing. Smaller networks must be smarter, more agile and more personalised in their approach to healthcare professionals. Izertis is a reference in supporting companies in transforming their efficiency model, turning data into decisions and decisions into results.
REP+ and network optimisation
We analyse and redesign the territorial structure of sales networks to maximise coverage of the highest-value healthcare professionals. Our models combine data on prescription, market potential and logistics variables to find the optimal configuration for each territory.
-
Data-based territorial redesign: target segmentation, geographical zones and balanced workload.
-
Analysis of coverage and optimal frequency by target, channel and product, identifying activity gaps and overvisits.
-
Real impact assessment with predictive models that simulate scenarios before executing changes in the network.
-
Dynamic territorial monitoring dashboards with activity, reach and penetration KPIs.
Propensity models and commercial intelligence
We turn scattered data into intelligent, prioritised business actions. Our propensity models help the sales network focus its efforts on the highest-impact interactions, moving from a frequency-based approach to a relevance-based approach.
-
Propensity models that predict the receptivity of each healthcare professional to specific messages and channels.
-
NBA models (Next Best Action) that recommend the optimal action for each representative in real time: visit, call, send content or wait.
-
Dynamic target scoring that updates with every interaction, integrating CRM, market and digital data.
-
Promotional impact analysis to quantify the real return of business activity on market share.
AI-powered training agents
Sales network training is a critical and often undervalued factor. We develop AI-powered conversational agents that allow delegates to train continuously, personalized and measurable, without relying on sporadic face-to-face sessions.
-
Continuous training of the network through simulations of medical visits adapted to each product and specialty.
-
Simulation of conversations with healthcare professionals of different profiles, objections and interest levels.
-
Improvement of sales arguments based on real effectiveness data: which messages generate the greatest impact by segment.
-
Automated skills assessment with immediate feedback and individualised development plans.
Real impact
More productivity per delegate, better segmentation of healthcare professionals and higher commercial ROI. Our approach is not based on theory, but on measurable results that transform our clients' business activity.
AI appllied to real processes
We are not talking about theoretical artificial intelligence or pilots that never reach production. At Izertis, we bring AI to real corporate processes in the pharmaceutical industry, with validated use cases, integrated governance, and regulatory compliance by design. Because in Pharma, AI without regulatory control is not innovation: it is a risk.
Route optimisation
Algorithms that calculate the optimal route for daily visits by integrating priority targets, location and travel time.
Duplicate detection
Intelligent matching models that unify databases of healthcare professionals and centres, eliminating duplication and improving the quality of master data.
Content generation
AI assistants that generate draft promotional materials, abstracts of scientific literature and medical communications aligned with compliance guidelines.
Reporting automation
Automated generation of business activity reports, KPI dashboards, and trend analysis that free up time for BI and business excellence teams.
Predictive analysis
Models that anticipate market trends, changes in prescribing patterns, and business opportunities before they are visible in historical data.
AI adoption roadmap: from exploration to scale
We accompany pharmaceutical companies in the definition and execution of their artificial intelligence adoption strategy, with a pragmatic approach that prioritizes business impact and regulatory viability over technological novelty.
Our roadmap covers every critical dimension:
Identification and prioritisation of cases
Comprehensive mapping of AI opportunities in business, medical, and operational processes, with prioritization based on impact, technical feasibility, and implementation effort
Technical and regulatory feasibility assessment
Analysis of each use case under criteria of technical feasibility, availability and quality of data, and alignment with the applicable regulatory framework (GDPR, MDR)
Data governance
Design of the data architecture needed to feed AI models: quality, traceability, lineage, access control, and retention policies
ISO 42001 Compliance
Implementation of the artificial intelligence management system in accordance with ISO/IEC 42001, ensuring that each deployed model complies with international standards for responsible AI
Our differential
AI with built-in governance and compliance from day one, not uncontrolled experimentation. In an industry where every interaction with a healthcare professional is regulated, responsible AI is not an option – it is a requirement.
Training, Compliance & Organisational Transformation
Technology without adoption does not transform. And adoption without regulatory compliance is an unacceptable risk in the pharmaceutical industry. Izertis closes the circle of transformation with training programs, compliance frameworks and solutions for the digitization of regulated processes that guarantee that innovation is deployed with the security that the sector demands.
Training
We design and execute tailor-made training programs for commercial, IT and management teams, ensuring that each profile acquires the necessary skills to operate with new tools and methodologies with confidence and autonomy.
-
Advanced CRM training: from the daily operation of delegates to the administration and configuration for IT teams
-
Responsible AI training for managers and technical teams: understanding models, their limits, and their ethical and regulatory implications
-
Digital adoption programmes with progress metrics, gamification and personalised tracking to accelerate the learning curve
REP+ and network optimisation
The relationship between the pharmaceutical industry and healthcare professionals is subject to strict regulatory frameworks. We digitalise these processes guaranteeing full compliance, complete traceability and operational efficiency without compromising transparency.
-
Digitisation of advisory boards and medical panels: call, document management, attendance and payment registration, with full traceability
-
Compliant management of medical interactions: consents, transfers of value, transparency statements and reporting to EFPIA/Farmindustria
-
Comprehensive control and traceability of every interaction, from invitation to administrative closure, with immutable audit trail
-
Automation of regulatory reporting: automatic generation of reports for competent authorities and industry associations
ISO 42001
Artificial Intelligence Management System
NIS2
Network and System Security Policy
ENS
National Security Scheme
GPDR
General Data Protection Regulation
MDR
Medical Device Regulations
IVDR
Regulations of Disp. In Vitro Diagnostics
Real impact
Technology aligned with regulation by design. We do not adapt generic solutions to the regulatory framework: we build each solution with compliance integrated into its architecture, avoiding costly remediation and reducing time-to-compliance.
Do you need more information?